CERVICAL INTRAEPITHELIAL NEOPLASIA, GRADE III

Clinical trials for CERVICAL INTRAEPITHELIAL NEOPLASIA, GRADE III explained in plain language.

Never miss a new study

Get alerted when new CERVICAL INTRAEPITHELIAL NEOPLASIA, GRADE III trials appear

Sign up with your email to follow new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA, GRADE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

DNA vaccine aims to train immune system against HPV-Linked cervical lesions

⭐️ VACCINE ⭐️ Recruiting now

This phase 1 trial tests a DNA vaccine designed to target HPV16, a virus that can cause high-grade cervical lesions (CIN2/3). The vaccine is given by injection into the muscle followed by a mild electrical pulse to help cells take up the DNA. The study includes both HIV-negative …

Matched conditions: CERVICAL INTRAEPITHELIAL NEOPLASIA, GRADE III

Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: ⭐️ VACCINE ⭐️

Last updated Jul 03, 2026 20:42 UTC

CERVICAL INTRAEPITHELIAL NEOPLASIA, GRADE III

Get alerted when new CERVICAL INTRAEPITHELIAL NEOPLASIA, GRADE III trials appear

DNA vaccine aims to train immune system against HPV-Linked cervical lesions